Barclays PLC T2 Biosystems, Inc. Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $13,505 - $27,597	-29,359 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$0.86 - $1.21 $18,559 - $26,113	21,581 Added 277.46%	29,359 $27,000
Q2 2021 Aug 13, 2021	SELL	$1.04 - $1.69 $146,463 - $238,002	-140,830 Reduced 94.77%	7,778 $9,000
Q1 2021 May 13, 2021	BUY	$1.32 - $3.79 $196,162 - $563,224	148,608 New	148,608 $241,000
Q4 2019 Feb 10, 2020	SELL	$0.96 - $2.94 $62,026 - $189,956	-64,611 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.58 - $3.01 $1,954 - $10,140	3,369 Added 5.5%	64,611 $162,000
Q2 2019 Aug 14, 2019	BUY	$1.47 - $3.16 $77,122 - $165,786	52,464 Added 597.68%	61,242 $103,000
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $36,124 - $63,217	-14,111 Reduced 61.65%	8,778 $23,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $109,815 - $252,797	-36,851 Reduced 61.69%	22,889 $69,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $214,207 - $312,918	39,964 Added 202.08%	59,740 $445,000
Q2 2018 Aug 14, 2018	SELL	$5.97 - $9.58 $26,900 - $43,167	-4,506 Reduced 18.56%	19,776 $154,000
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $39,018 - $64,876	-9,268 Reduced 27.62%	24,282 $158,000
Q4 2017 Feb 14, 2018	BUY	$3.73 - $4.6 $125,141 - $154,330	33,550	33,550 $138,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.6M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.